Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
United States: Infrequent sleep, particularly chronic sleep, in adults aged 45 and older is associated with numerous measures of...
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.
2.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
3.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
4.
A Lot Can Be Said About You by Including Yourself in Photos.
5.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
1.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
2.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
3.
Understanding the Rare Disease: Werner Syndrome Explained
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
Navigating the Complexities of Ph Negative ALL - Part I
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge